IMRIS Company Profile (TSE:IM)


IMRIS logoImaging Canada Liquidating Corp, formerly IMRIS Inc (IMRIS), is a Canada-based company, which designs, manufactures and markets the VISIUS Surgical Theatre, a multifunctional surgical environment that provides intraoperative vision to clinicians to assist in decision-making and precision in treatment. It can incorporate magnetic resonance (MR) imaging, computed tomography (CT) imaging and x-ray angiography in various configurations. IMRIS sells the VISIUS Surgical Theatres to hospitals that deliver clinical services to patients in the neurosurgical, spinal, cerebrovascular and cardiovascular markets. Its VISIUS iMRI provides imaging using Siemens 1.5T (tesla) and 3T MR core technology to enable imaging capabilities, including spectroscopy, fMRI and DTI. Its SYMBIS Surgical System is an MR and CT-compatible image guided surgical robot. Its VISIUS iCT is a multifunctional surgical theater that brings CT image quality with low dose management directly to patients in the operating room.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: TSE:IM
  • CUSIP: N/A
  • Web: N/A
  • Trailing P/E Ratio:
  • P/E Growth:
  • Net Margins: -73.94%
  • Return on Equity: -213.57%
  • Return on Assets: -45.35%
Frequently Asked Questions for IMRIS (TSE:IM)

What is IMRIS's stock symbol?

IMRIS trades on the Tornton Stock Exchange (TSX) under the ticker symbol "IM."

Who are some of IMRIS's key competitors?

How do I buy IMRIS stock?

Shares of IMRIS and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is IMRIS's stock price today?

One share of IMRIS stock can currently be purchased for approximately C$0.80.

MarketBeat Community Rating for IMRIS (TSE IM)
Community Ranking:  2.2 out of 5 ( )
Outperform Votes:  4 (Vote Outperform)
Underperform Votes:  5 (Vote Underperform)
Total Votes:  9
MarketBeat's community ratings are surveys of what our community members think about IMRIS and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for IMRIS (TSE:IM) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for IMRIS (TSE:IM)
No equities research coverage for this company has been tracked by


Earnings History for IMRIS (TSE:IM)
No earnings announcements for this company have been tracked by


Earnings Estimates for IMRIS (TSE:IM)
Current Year EPS Consensus Estimate: $-0.21 EPS


Dividend History for IMRIS (TSE:IM)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for IMRIS (TSE:IM)
Insider Trades by Quarter for IMRIS (TSE:IM)
Insider Trades by Quarter for IMRIS (TSE:IM)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/29/2014Meir DahanInsiderBuy20,000C$0.43C$8,620.00
(Data available from 1/1/2013 forward)


Headline Trends for IMRIS (TSE:IM)
Latest Headlines for IMRIS (TSE:IM)
DateHeadline logoGlobal MRI Systems Market 2016-2021 - January 21 at 1:27 PM logoTSX Delisting Review - IMRIS Inc. (Symbol: IM) - June 3 at 8:30 AM logoTSX Delisting Review - SouthGobi Resources Ltd. (Symbol: IM) - May 26 at 10:01 AM logoIIROC Trading Halt - IM - May 26 at 8:26 AM



IMRIS (IM) Chart for Tuesday, July, 25, 2017

This page was last updated on 7/25/2017 by Staff